Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03573934
Other study ID # UCHP-KS-2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 15, 2017
Est. completion date March 15, 2018

Study information

Verified date January 2020
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Effects of GLP-2 and GIP on bone remodeling in healthy young men.


Description:

We will investigate acute effects of GLP-2 and GIP on bone remodeling in healthy young men.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date March 15, 2018
Est. primary completion date March 15, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

Age between 20 and 40 years old Caucasian Healthy BMI between 18.5 and 24.9 kg/m2.

Exclusion Criteria:

Chronic disease Smoking Medication Weight change more than 3 kg whitin the last 3 months Overweight surgery Intestinal surgery Hgb<8,0 mmol/L Decreased renal function.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
GLP-2
GLP-2
GIP
GIP
GLP-2+GIP
GLP-2+GIP
Placebo
Placebo

Locations

Country Name City State
Denmark Hvidovre University Hospital Hvidovre

Sponsors (2)

Lead Sponsor Collaborator
University of Copenhagen Hvidovre University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Heart rate Before blood sampling From -10 minutes to 240 minutes.
Other Blood pressure Before blood sampling From -10 minutes to 240 minutes.
Primary Bone resorption C-terminal telopeptide (CTX) is a marker of bone resorption. Measured in serum. From -10 minutes to 240 minutes.
Primary Bone formation P1NP is a marker of bone formation. Measured in serum. From -10 minutes to 240 minutes.
Secondary Parathyroid hormone PTH is a bone marker From -10 minutes to 240 minutes.
Secondary Calcium Measured in serum. From -10 minutes to 240 minutes.
Secondary GIP Intact and total GIP. From -10 minutes to 240 minutes.
Secondary GLP-2 Intact GLP-2 From -10 minutes to 240 minutes.
Secondary Glucose Measured in serum. From -10 minutes to 240 minutes.
Secondary Insulin Measured in serum. From -10 minutes to 240 minutes.
Secondary C-peptide Measured in serum. From -10 minutes to 240 minutes.
Secondary Sclerostin Bone marker. From -10 minutes to 240 minutes.
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1